A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant

Abstract

Abstract Seizure threshold‐2 (SZT2) gene variants have been associated with a decrease in seizure threshold resulting in variable phenotypic expressions ranging from mild‐moderate intellectual disabilities without seizures, to an early‐onset epileptic encephalopathy with severe cognitive impairment. In addition, hypotonia and distinctive facial dysmorphism, including a high forehead and to a lesser extent ptosis and down‐slanting palpebral fissures, were present in the majority. We herein report a novel SZT2 variant in one of two siblings both diagnosed with epilepsy of infancy with migrating focal seizures (EIMFS). This report is the fourth to document a possible familial case in EIMFS, a condition that was not previously associated with SZT2 variant. This report expands the phenotypic expression of SZT2, corroborates the importance of genetic counseling in some cases of EIMFS, and highlights the efficacy of potassium bromide in controlling the seizures associated with this condition.

Keywords

• familial epilepsy of infancy with migrating focal seizures
• infantile epileptic encephalopathy
• potassium bromide
• SZT2